Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sohm Inc (OP:SHMN)

0.0008 -0.0001 (-11.11%)
Streaming Delayed Price Updated: 3:46 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sohm Inc

< Previous 1 2 3 Next >
BioMedNewsBreaks — Why SOHM Inc. (SHMN) Is ‘One to Watch’
Via Investor Brand Network
Senate Committee Hears How Drug Shortages Impact Patients
Via Investor Brand Network
SOHM Inc.’s (SHMN) New Gene-Editing Technology Holds Potential to Revolutionize the Field of Cardiology, With Superior Capabilities Over Other Gene-Editing Systems
Via Investor Brand Network
SOHM Inc. (SHMN) Taps into UACI’s Robust Resources and Specialized Infrastructure for ABBIE Advancement
Via Investor Brand Network
SOHM Inc. (SHMN) Is ‘One to Watch’
Via Investor Brand Network
BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces 2024 Outlook for Business Units
Via Investor Brand Network
SOHM Announces Business Outlook for 2024
From SOHM, Inc.
Via GlobeNewswire
Topical Analgesics Emerge as Important Pain-Management Tools
Via Investor Brand Network
BioMedNewsBreaks – SOHM, Inc. (SHMN) Launches Carlsbad-Based CDMO GMP Manufacturing Facility
Via Investor Brand Network
SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California
From SOHM, Inc.
Via GlobeNewswire
Study Shows Patients Afflicted by Inflammatory Arthritis Face Numerous Mental Challenges at Work
Via Investor Brand Network
BioMedNewsBreaks – SOHM Inc. (SHMN) Unveils New Suite of SOHM Nutrients’ Brand Chewables
Via Investor Brand Network
SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables
From SOHM, Inc.
Via GlobeNewswire
BioMedNewsBreaks – SOHM Inc.’s (SHMN) ABBIE Technology Poised to Make a Difference in the Lives of Millions
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Meta-Analysis Says Nutraceuticals Show Potential in Acne Treatment
Via Investor Brand Network
SOHM, Inc. (SHMN) Completes Acquisition of ABBIE Gene-editing Tech, Begins Preparations to Commercialize Solutions for Heart Disease
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
SOHM, Inc. (SHMN) Bolsters Executive Team; Confident About Anticipated Developments and Opportunities
Via Investor Brand Network
BioMedNewsBreaks – SOHM, Inc. (SHMN), UACI Collaborate to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
Via Investor Brand Network
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
From SOHM, Inc.
Via GlobeNewswire
BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces Acquisition of World-Class Gene-Editing Platform
Via Investor Brand Network
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
From SOHM, Inc.
Via GlobeNewswire
BioMedNewsBreaks — SOHM Inc. (SHMN) Expands Team to Direct Global Growth Strategy
Via Investor Brand Network
Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology
Via Investor Brand Network
Topics Economy
Exposures Supply Chain
Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development
Via Investor Brand Network
BioMedNewsBreaks – SOHM Inc. (SHMN) Names Seasoned Veteran as VP of Quality
Via Investor Brand Network
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect
From SOHM, Inc.
Via GlobeNewswire
BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces Strategic Board Appointment of Dr. Krishna Bhat, MD, Ph.D., FACC
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor
From SOHM, Inc.
Via GlobeNewswire
SOHM, Inc. Announce the Appointment of Dr. David Aguilar, Ph.D. as a Chief Operating Officer with the Company with Immediate Effect
Via ACCESSWIRE
SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents
Via ACCESSWIRE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.